miR-423-3p as a Biomarker of Diabetic Retinopathy in Patients with Type 2 Diabetes in the Kazakh Population
Main Article Content
Authors
Aizhan Magazova
Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan
International Medical School, Caspian University, Almaty, Kazakhstan
Almaty Multidisciplinary Clinical Hospital, Almaty, Kazakhstan
Aigul Balmukhanova
International Medical School, Caspian University, Almaty, Kazakhstan
Kamalidin Sharipov
Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan
Yeldar Ashirbekov
Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan
Abstract
Background: Diabetic retinopathy (DR) is a leading cause of blindness among working-age individuals globally. In Kazakhstan, the prevalence of type 2 diabetes mellitus (T2DM) is rising, making DR a significant public health concern. Early detection of DR is challenging due to its asymptomatic onset, necessitating the identification of reliable biomarkers for timely diagnosis.
Objective: This study aimed to evaluate the potential of plasma microRNAs (miRNAs) as biomarkers for DR in the Kazakhstani population.
Materials and Methods: We conducted a case-control study involving 100 T2DM patients with DR, 98 T2DM patients without DR, and 30 healthy controls. Plasma samples were collected from four medical institutions in Almaty between 2020 and 2021. Quantitative real-time PCR was employed to assess the expression levels of ten candidate miRNAs. Statistical analyses included Mann– Whitney U tests, Pearson’s χ² tests, Spearman’s correlation coefficients, and multiple linear regression. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic performance of miRNAs.
Results: The expression level of miR-423-3p was significantly lower in DR patients compared to those without DR (pFDR = 5.4 × 10−3). Additionally, miR-423-3p levels were reduced in DR patients compared to healthy controls (pFDR = 5.4 × 10−3). However, the diagnostic accuracy of miR- 423-3p was limited, with area under the curve (AUC) values ranging from 0.6 to 0.7, indicating poor diagnostic potential.
Conclusion: While miR-423-3p demonstrates differential expression in DR patients, its low diagnostic accuracy precludes its use as a standalone biomarker for DR in the Kazakhstani population. Further research is needed to identify more reliable biomarkers for early detection of DR.
Acknowledgements: We thank the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan for funding this research (grant AP08857430).
Key words: miR-423-3p, Diabetic Retinopathy, Type 2 Diabetes, Biomarker, Plasma microRNA, Kazakh Population